ArticleDementia and neurocognitive disorders2026
Stage-Specific Efficacy of Lecanemab and Donanemab in Early Alzheimer's Disease: An Indirect, Comparative Interpretation of Phase 3 Trials.
YongSoo ShimPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.